MRGPRX11P

Across TCGA pan-cancer cohorts, MRGPRX11P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MRGPRX11P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MRGPRX11P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MRGPRX11P expression acts as an unfavorable survival marker.

STAD, UCS, and KIRP are the cancer types where MRGPRX11P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.365	0.675	<.001	105	view →
UCS	OS	Tertile	All	0.135	0.687	.009	72	view →
KIRP	OS	Tertile	II,III,IV	0.161	0.771	.002	63	view →
ACC	OS	Tertile	All	0.188	0.820	<.001	36	view →
GBM	OS	Tertile	All	0.111	0.415	.005	27	view →
SARC	OS	Tertile	All	0.144	0.594	.005	27	view →
KIRC	DFS	Tertile	IV	0.167	0.605	<.001	18	view →
SKCM	DFS	Tertile	IV	0.016	0.454	<.001	18	view →
CESC	DFS	Tertile	II,III,IV	0.173	0.705	.028	18	view →
HNSC	DFS	Tertile	IV	0.203	0.584	.048	9	view →
UCEC	OS	Tertile	III,IV	0.650	0.833	.033	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MRGPRX11P–STAD (DFS)

Open the STAD breakdown →